Anbio Biotechnology NNNN Institutional Ownership

NASDAQ NNNN

$3.72 -0.01 (-0.27%)

At close: Oct 21, 2026 · 4:00 PM EDT

Institutions by Trading Activity

12 Institutions

Increased 8 66.7%

Unchanged 1 8.3%

Reduced 3 25.0%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

0.05%

▲+0.01 pp QoQ

Shares Held by Institutions

71.86K

of 143.89Mn outstanding

▲+39.83% QoQ

Shares Outstanding

143.89Mn

143.82Mn held outside 13F filers

Institutional Investors

filed 13F for Jun 2026

▲+4 vs prior quarter

Net Shares Added (QoQ)

+20.47K

accumulated since last quarter

Value of Holdings

$268.03K

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Updated Oct 10, 2026

Anbio Biotechnology (NASDAQ:NNNN) appeared in the 13F filings of 12 institutional investors for the quarter ended June 30, 2026.

Their combined stake equaled 0.05% of outstanding shares in Q2 2026, up from 0.04% in Q1 2026.
Total shares held in Anbio Biotechnology rose 39.83% from Q1 2026, while the number of holders rose 200.00% from Q2 2025.
Of the 12 holders of NNNN in Q2 2026, 8 added to their positions, 3 reduced their stakes and 1 left its position unchanged.
Combined, institutional investors held 71.86K shares of NNNN as of Q2 2026, up 20.47K from the prior quarter and up 42.67K from a year earlier.
As of June 30, 2026, Geode Capital Management, LLC held the largest stake in Anbio Biotechnology with 26.74K shares, or 0.02% of shares outstanding.
Among existing holders, the largest additions to Anbio Biotechnology in Q2 2026 came from BNP Paribas Financial Markets (+1.4K shares) and Geode Capital Management, LLC (+973 shares).
Among holders that kept a stake in Anbio Biotechnology, the biggest sellers in Q2 2026 were UBS Group AG (-5.51K shares), EverSource Wealth Advisors, LLC (-1.24K shares) and Morgan Stanley (-107 shares).
Per Business Quant data, the 10 largest holders of Anbio Biotechnology at the end of Q2 2026 were Geode Capital Management, LLC (26.74K shares), Bank of America Corp (13.42K shares), BNP Paribas Financial Markets (11.8K shares), Marshall Wace, LLP (11.5K shares), Morgan Stanley (7.23K shares), UBS Group AG (828 shares), EverSource Wealth Advisors, LLC (187 shares), Osaic Holdings, Inc. (77 shares), JPMorgan Chase & Co (53 shares) and Bare Financial Services, Inc (15 shares).

Form 13F Holdings

12 Institutional Holders

Report period 30 Jun, 2026

Total shares held 71.86K

Of outstanding 0.05%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	GEODE CAPITAL MANAGEMENT, LLC	0001214717	26,736	0.02%	▲973	+3.78%	$366.55K
2	Bank Of America Corp /De/	0000070858	13,419	0.01%	▲13,419	0.00%	$183.97K
3	BNP PARIBAS FINANCIAL MARKETS	0001166588	11,800	0.01%	▲1,400	+13.46%	$161.78K
4	MARSHALL WACE, LLP	0001318757	11,502	0.01%	▲11,502	0.00%	$157.69K
5	Morgan Stanley	0000895421	7,231	0.01%	▼107	-1.46%	$99.14K
6	UBS Group AG	0001610520	828	0.00%	▼5,511	-86.94%	$11.35K
7	EverSource Wealth Advisors, LLC	0001710537	187	0.00%	▼1,243	-86.92%	$2.56K
8	OSAIC HOLDINGS, INC.	0001677044	77	0.00%	▲77	0.00%	$1.06K
9	Jpmorgan Chase & Co	0000019617	53	0.00%	▲53	0.00%	$718
10	Bare Financial Services, Inc	0002009426	15	0.00%	0	0.00%	$206
11	Larson Financial Group LLC	0001731061	5	0.00%	▲5	0.00%	$69
12	Silver Grove Financial Group, Inc.	0002111172	4	0.00%	▲4	0.00%	$55